Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-01

Clinical Trial Update: Pharmacokinetics of Nalbuphine Injection [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic data for nalbuphine injection in postoperative pain patients are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalbuphine injection (nalbuphine)

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Pain, Postoperative | Phase 4 | Status: COMPLETED